Patent · US Active

Pyrazolopyrimidine compounds

US10131669B2 · kind B2 · utility

0Cited by

11References

3Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Thomas Allen Chappie · Old Lyme, US
Patrick Robert Verhoest · Newton, US
Nandini Chaturbhai Patel · Newton, US
Matthew Merrill Hayward · Old Lyme, US
Christopher John Helal · Mystic, US
Simone Sciabola · Cambridge, US
Travis T. Wager · Brookline, US
Erik Alphie LaChapelle · Uncasville, US
Joseph Michael Young · Madison, US

Key dates

Filing date	Jul 10, 2015
Grant date	Nov 20, 2018
Priority date	—
Expiry date	Jul 10, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to pyrazolopyrimine compounds or pharmaceutically acceptable salts which are inhibitors of PDE4 isozymes, especially with a binding affinity for PDE4B isoform, and compositions thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.